8q24 sequence variants in relation to prostate cancer risk among men of African descent: A case-control study

被引:16
作者
Benford, Marnita L. [1 ,2 ]
VanCleave, Tiva T. [1 ,2 ]
Lavender, Nicole A. [1 ,2 ]
Kittles, Rick A. [3 ]
Kidd, LaCreis R. [1 ,2 ]
机构
[1] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
[2] Univ Louisville, James Graham Brown Canc Ctr, Canc Prevent Program, Louisville, KY 40292 USA
[3] Univ Illinois, Dept Med, Chicago, IL USA
来源
BMC CANCER | 2010年 / 10卷
关键词
CHROMOSOME; 8Q24; ASSOCIATION; AMERICANS; LOCI; CONFIRMATION; DIAGNOSIS; ANCESTRY;
D O I
10.1186/1471-2407-10-334
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human chromosome 8q24 has been implicated in prostate tumorigenesis. Methods: Consequently, we evaluated seven 8q24 sequence variants relative to prostate cancer (PCA) in a case-control study involving men of African descent. Genetic alterations were detected in germ-line DNA from 195 incident PCA cases and 531 controls using TaqMan polymerase chain reaction (PCR). Results: Inheritance of the 8q24 rs16901979 T allele corresponded to a 2.5-fold increase in the risk of developing PCA for our test group. These findings were validated using multifactor dimensionality reduction (MDR) and permutation testing (p = 0.038). The remaining 8q24 targets were not significantly related to PCA outcomes. Conclusions: Although compelling evidence suggests that the 8q24 rs16901979 locus may serve as an effective PCA predictor, our findings require additional evaluation in larger studies.
引用
收藏
页数:7
相关论文
共 28 条
  • [1] American Cancer Society, Cancer facts & figures for African Americans 2019-2021
  • [2] A common variant associated with prostate cancer in European and African populations
    Amundadottir, Laufey T.
    Sulem, Patrick
    Gudmundsson, Julius
    Helgason, Agnar
    Baker, Adam
    Agnarsson, Bjarni A.
    Sigurdsson, Asgeir
    Benediktsdottir, Kristrun R.
    Cazier, Jean-Baptiste
    Sainz, Jesus
    Jakobsdottir, Margret
    Kostic, Jelena
    Magnusdottir, Droplaug N.
    Ghosh, Shyamali
    Agnarsson, Kari
    Birgisdottir, Birgitta
    Le Roux, Louise
    Olafsdottir, Adalheidur
    Blondal, Thorarinn
    Andresdottir, Margret
    Gretarsdottir, Olafia Svandis
    Bergthorsson, Jon T.
    Gudbjartsson, Daniel
    Gylfason, Arnaldur
    Thorleifsson, Gudmar
    Manolescu, Andrei
    Kristjansson, Kristleifur
    Geirsson, Gudmundur
    Isaksson, Helgi
    Douglas, Julie
    Johansson, Jan-Erik
    Balter, Katarina
    Wiklund, Fredrik
    Montie, James E.
    Yu, Xiaoying
    Suarez, Brian K.
    Ober, Carole
    Cooney, Kathleen A.
    Gronberg, Henrik
    Catalona, William J.
    Einarsson, Gudmundur V.
    Barkardottir, Rosa B.
    Gulcher, Jeffrey R.
    Kong, Augustine
    Thorsteinsdottir, Unnur
    Stefansson, Kari
    [J]. NATURE GENETICS, 2006, 38 (06) : 652 - 658
  • [3] [Anonymous], Multifactor dimensionality reduction as a filter-based approach for genome wide association studies. - PubMed - NCBI
  • [4] [Anonymous], Cancer Facts and Figures 2009
  • [5] 8q24 and prostate cancer: association with advanced disease and meta-analysis
    Cheng, Iona
    Plummer, Sarah J.
    Jorgenson, Eric
    Liu, Xin
    Rybicki, Benjamin A.
    Casey, Graham
    Witte, John S.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (04) : 496 - 505
  • [6] Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer
    Cussenot, Olivier
    Azzouzi, Abdel-Rahmene
    Bantsimba-Malanda, Gladys
    Gaffory, Cecile
    Mangin, Philippe
    Cormier, Luc
    Fournier, Georges
    Valeri, Antoine
    Jouffe, Lionel
    Roupret, Morgan
    Fromont, Gaelle
    Sibony, Mathilde
    Comperat, Eva
    Cancel-Tassin, Geraldine
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (17) : 5635 - 5639
  • [7] Analysis of Recently Identified Prostate Cancer Susceptibility Loci in a Population-based Study: Associations with Family History and Clinical Features
    FitzGerald, Liesel M.
    Kwon, Erika M.
    Koopmeiners, Joseph S.
    Salinas, Claudia A.
    Stanford, Janet L.
    Ostrander, Elaine A.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3231 - 3237
  • [8] HISTOLOGIC GRADING OF PROSTATE-CANCER - A PERSPECTIVE
    GLEASON, DF
    [J]. HUMAN PATHOLOGY, 1992, 23 (03) : 273 - 279
  • [9] GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125
  • [10] Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
    Gudmundsson, Julius
    Sulem, Patrick
    Manolescu, Andrei
    Amundadottir, Laufey T.
    Gudbjartsson, Daniel
    Helgason, Agnar
    Rafnar, Thorunn
    Bergthorsson, Jon T.
    Agnarsson, Bjarni A.
    Baker, Adam
    Sigurdsson, Asgeir
    Benediktsdottir, Kristrun R.
    Jakobsdottir, Margret
    Xu, Jianfeng
    Blondal, Thorarinn
    Kostic, Jelena
    Sun, Jielin
    Ghosh, Shyamali
    Stacey, Simon N.
    Mouy, Magali
    Saemundsdottir, Jona
    Backman, Valgerdur M.
    Kristjansson, Kristleifur
    Tres, Alejandro
    Partin, Alan W.
    Albers-Akkers, Marjo T.
    Marcos, Javier Godino-Ivan
    Walsh, Patrick C.
    Swinkels, Dorine W.
    Navarrete, Sebastian
    Isaacs, Sarah D.
    Aben, Katja K.
    Graif, Theresa
    Cashy, John
    Ruiz-Echarri, Manuel
    Wiley, Kathleen E.
    Suarez, Brian K.
    Witjes, J. Alfred
    Frigge, Mike
    Ober, Carole
    Jonsson, Eirikur
    Einarsson, Gudmundur V.
    Mayordomo, Jose I.
    Kiemeney, Lambertus A.
    Isaacs, William B.
    Catalona, William J.
    Barkardottir, Rosa B.
    Gulcher, Jeffrey R.
    Thorsteinsdottir, Unnur
    Kong, Augustine
    [J]. NATURE GENETICS, 2007, 39 (05) : 631 - 637